Silverfin false false 31/03/2025 01/04/2024 31/03/2025 Dr S S Kandola 26/07/2024 K K Kandola 26/07/2024 08 December 2025 The principal activity of the company during the financial year was other human health activities. 15861162 2025-03-31 15861162 bus:Director1 2025-03-31 15861162 bus:Director2 2025-03-31 15861162 core:CurrentFinancialInstruments 2025-03-31 15861162 core:ShareCapital 2025-03-31 15861162 core:RetainedEarningsAccumulatedLosses 2025-03-31 15861162 core:PlantMachinery 2024-03-31 15861162 core:FurnitureFittings 2024-03-31 15861162 2024-03-31 15861162 core:PlantMachinery 2025-03-31 15861162 core:FurnitureFittings 2025-03-31 15861162 core:CurrentFinancialInstruments 10 2025-03-31 15861162 bus:OrdinaryShareClass1 2025-03-31 15861162 bus:OrdinaryShareClass2 2025-03-31 15861162 2024-04-01 2025-03-31 15861162 bus:FilletedAccounts 2024-04-01 2025-03-31 15861162 bus:SmallEntities 2024-04-01 2025-03-31 15861162 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 15861162 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 15861162 bus:Director1 2024-04-01 2025-03-31 15861162 bus:Director2 2024-04-01 2025-03-31 15861162 core:PlantMachinery 2024-04-01 2025-03-31 15861162 core:FurnitureFittings 2024-04-01 2025-03-31 15861162 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 15861162 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 15861162 (England and Wales)

PLATINUM MIND THERAPY LTD

Unaudited Financial Statements
For the financial period ended 31 March 2025
Pages for filing with the registrar

PLATINUM MIND THERAPY LTD

Unaudited Financial Statements

For the financial period ended 31 March 2025

Contents

PLATINUM MIND THERAPY LTD

STATEMENT OF FINANCIAL POSITION

As at 31 March 2025
PLATINUM MIND THERAPY LTD

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 March 2025
Note 2025
£
Fixed assets
Tangible assets 3 11,229
11,229
Current assets
Debtors 4 1,986
1,986
Creditors: amounts falling due within one year 5 ( 41,391)
Net current liabilities (39,405)
Total assets less current liabilities (28,176)
Net liabilities ( 28,176)
Capital and reserves
Called-up share capital 6 100
Profit and loss account ( 28,276 )
Total shareholders' deficit ( 28,176)

For the financial period ending 31 March 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Platinum Mind Therapy Ltd (registered number: 15861162) were approved and authorised for issue by the Board of Directors on 08 December 2025. They were signed on its behalf by:

K K Kandola
Director
PLATINUM MIND THERAPY LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial period ended 31 March 2025
PLATINUM MIND THERAPY LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial period ended 31 March 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.

General information and basis of accounting

Platinum Mind Therapy Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 8 Clarendon Place, Leamington Spa, Warwickshire, CV32 5QN, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors note that the business has net liabilities of £28,176. The Company is supported through loans from the directors. The directors have confirmed that the loan facilities will continue to be available for at least 12 months from the date of signing these financial statements and the directors will continue to support the Company. Given the current position, the directors believe that any foreseeable debts can be met for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Tangible fixed assets

Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended. Depreciation is provided on all tangible fixed assets, other than investment properties and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a [straight-line/reducing balance] basis over its expected useful life, as follows:

Plant and machinery 25 % reducing balance
Fixtures and fittings 25 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Provisions

Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Statement of Financial Position date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).

When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.

Ordinary share capital

The ordinary share capital of the Company is presented as equity.

2. Employees

2025
Number
Monthly average number of persons employed by the Company during the period, including directors 2

3. Tangible assets

Plant and machinery Fixtures and fittings Total
£ £ £
Cost
At 01 April 2024 0 0 0
Additions 2,126 10,257 12,383
At 31 March 2025 2,126 10,257 12,383
Accumulated depreciation
At 01 April 2024 0 0 0
Charge for the financial period 96 1,058 1,154
At 31 March 2025 96 1,058 1,154
Net book value
At 31 March 2025 2,030 9,199 11,229

4. Debtors

2025
£
Amounts owed by directors 90
Other taxation and social security 1,896
1,986

5. Creditors: amounts falling due within one year

2025
£
Other creditors 41,391

6. Called-up share capital

2025
£
Allotted, called-up and fully-paid
90 A ordinary shares of £ 1.00 each 90
10 B ordinary shares of £ 1.00 each 10
100

7. Related party transactions

Transactions with the entity's directors

2025
£
Amounts owed to Directors (9,934)
Amounts owed by Directors 90